Rao Sriram D, Adusumalli Srinath, Mazurek Jeremy A
Advanced Heart Failure/Transplantation Programme, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania Philadelphia, PA, US.
Department of Medicine, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania Philadelphia, PA, US.
Card Fail Rev. 2020 Apr 9;6:e05. doi: 10.15420/cfr.2019.09. eCollection 2020 Mar.
The development of pulmonary hypertension (PH) in patients with heart failure is associated with increased morbidity and mortality. In this article, the authors examine recent changes to the definition of PH in the setting of left heart disease (PH-LHD), and discuss its epidemiology, pathophysiology and prognosis. They also explore the complexities of diagnosing PH-LHD and the current evidence for the use of medical therapies, promising clinical trials and the role of left ventricular assist device and transplantation.
心力衰竭患者发生肺动脉高压(PH)与发病率和死亡率增加相关。在本文中,作者探讨了左心疾病相关肺动脉高压(PH-LHD)定义的近期变化,并讨论了其流行病学、病理生理学和预后。他们还探讨了PH-LHD诊断的复杂性以及使用药物治疗的现有证据、有前景的临床试验以及左心室辅助装置和移植的作用。